Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001749432-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-03+ | OLMA | Mitchell Shawnte | CLO | S - Sale+OE | $23.79 | -40.0K | 233 | -99% | -$951.5K |
| DM | 2026-03-05 | 2026-03-03+ | OLMA | Mitchell Shawnte | CLO | M - OptEx | $4.37 | +40.0K | 15.0K | New | +$174.8K |
| DM | 2026-03-05 | 2026-03-03+ | OLMA | Mitchell Shawnte | CLO | M - OptEx | $0.00 | -40.0K | 410.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | S | D | 15,000 | $23.01 | 0 | D | — | — | (F1) The weighted average sale price for the transaction reported was $23.01, and the range of prices were between $22.89 and $23.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Comon Stock | 2026-03-04 | S | D | 233 | $24.69 | 0 | D | — | — | (F3) The weighted average sale price for the transaction reported was $24.69, and the range of prices were between $24.68 and $24.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2026-03-04 | M | A | 25,000 | $4.37 | 25,000 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-04 | S | D | 24,767 | $24.25 | 233 | D | — | — | (F2) The weighted average sale price for the transaction reported was $24.25, and the range of prices were between $23.68 and $24.64. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 5 | Common | Common Stock | 2026-03-03 | M | A | 15,000 | $4.37 | 15,000 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | M | D | 15,000 | $0.00 | 435,000 | D | $4.37 · — to 2035-02-27 | 15,000 Common Stock | (F4) 25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-03-04 | M | D | 25,000 | $0.00 | 410,000 | D | $4.37 · — to 2035-02-27 | 25,000 Common Stock | (F4) 25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |